Focus Partners Wealth’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.3M Buy
286,346
+33,613
+13% +$2.94M 0.03% 449
2026
Q1
$21.5M Buy
252,733
+9,997
+4% +$891K 0.02% 482
2025
Q4
$19.2M Buy
242,736
+46,856
+24% +$3.67M 0.02% 501
2025
Q3
$15.5M Buy
195,880
+9,674
+5% +$825K 0.03% 450
2025
Q2
$16.9M Buy
186,206
+5,016
+3% +$458K 0.04% 393
2025
Q1
$17M Buy
181,190
+1,554
+0.9% +$139K 0.04% 362
2024
Q4
$16.3M Buy
179,636
+33,219
+23% +$3.17M 0.04% 359
2024
Q3
$15.2M Sell
146,417
-43,943
-23% -$4.48M 0.05% 328
2024
Q2
$18.5M Buy
190,360
+104,499
+122% +$9.64M 0.06% 262
2024
Q1
$7.73M Buy
85,861
+33,719
+65% +$2.86M 0.06% 247
2023
Q4
$4.16M Buy
+52,142
New +$3.92M 0.05% 258

Other funds holding CL

Focus Partners Wealth's CL Position: Q2 2026 in Review

Focus Partners Wealth increased its Colgate-Palmolive (CL) stake by 13% in Q2 2026, buying an estimated $2.94M and bringing the position to 286,346 shares worth $26.3M. The position accounts for 0.03% of the portfolio, ranked #449.

Focus Partners Wealth first reported a position in CL in Q4 2023 and has held it in 11 quarters since. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Focus Partners Wealth held 286,346 shares of Colgate-Palmolive worth $26.3M as of Q2 2026.
  • Focus Partners Wealth bought 33,613 Colgate-Palmolive shares in Q2 2026, an estimated $2.94M.
  • Colgate-Palmolive made up 0.03% of Focus Partners Wealth's portfolio in Q2 2026, its #449 holding.
  • Focus Partners Wealth first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.